Development
PROCEPT BioRobotics Corporation
PRCT
$62.91
-$2.14-3.29%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -11.70% | 2.63% | 11.22% | -1.11% | -24.58% |
| Total Depreciation and Amortization | 25.05% | 64.17% | -19.04% | 19.61% | -5.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.70% | 11.80% | 14.82% | -37.19% | 70.03% |
| Change in Net Operating Assets | -213.79% | 87.35% | 30.53% | -165.57% | -124.80% |
| Cash from Operations | -30.88% | 33.16% | 21.12% | -42.72% | -26.81% |
| Capital Expenditure | -50.78% | -7.59% | -0.62% | -516.51% | 42.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -50.78% | -7.59% | -0.62% | -516.51% | 42.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.23% | 6,571.56% | 539.47% | -74.45% | 91.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.23% | 6,571.56% | 539.47% | 128.83% | -269.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -122.30% | 539.23% | 23.49% | -49.45% | -32.88% |